Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Family Medicine
Ocular Hypertension Clinical Trials
A listing of Ocular Hypertension medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Artesia : Kenneth Sall, M.D.
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Artesia : Artesia Clinical Site - Site 02
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Inglewood : United Medical Research Institute
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Inglewood : Inglewood Clinical Site - Site 03
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
La Jolla : University of California San Diego Updated
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
View More »
Newport Beach : Aesthetic Eye Care Institute
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Petaluma : Bacharach practice
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Petaluma : Petaluma Clinical Site - Site 05
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Poway : Centre For Health Care
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
San Francisco : Glaucoma Center of San Francisco
The Efficacy of Selective Laser Trabeculoplasty
Connecticut
New Haven : New Haven Clinical Site - Site 01
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Georgia
Atlanta : Atlanta Clinical Site - Site 04
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Morrow : Clayton Eye Center
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Roswell : Coastal Research Associates, LLC
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Kansas
Shawnee Mission : Bradley Kwapiszeski, MD
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Kentucky
Lexington : University of Kentucky
Safety Study of Latanoprost Slow Release Insert
Lexington : Univ of Ky
Safety Study of Latanoprost Slow Release Insert
Louisville : Taustine Eye Center
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Maryland
Baltimore : Alan L Robin, M.D.
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Havre de Grace : Seidenberg Protzko Eye Associates
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Michigan
St. Joseph : Great Lakes Eye Care
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
New York
Bronx : Jeffrey Schultz, M.D.
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Rochester : Rochester Ophthalmological Group
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Rochester : Bausch & Lomb Inc. Updated
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Rochester : Bausch & Lomb Inc. Updated
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Rochester :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
North Carolina
Belmont : Charlotte Eye Ear Nose & Throat Associates, P.A.
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
High Point : High Point Clinical Site - Site 06
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Oklahoma
Tulsa : The Eye Institute
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Texas
Austin : Texan Eye
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
Fort Worth : Contact Alcon Call Center for Trial Locations
Efficacy of Changing to Travatan From Prior Therapy
Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
San Antonio : Medical Center Ophth. Associates
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Utah
Salt Lake City : Stacy R. Smith, M.D.
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Virginia
Norfolk : Virginia Eye Consultants
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Armenia
Yerevan : S.V. Malayan Ophthalmological Center
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Australia
Fitzroy :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Belgium
Edegem : Universitair Ziekenhuis Antwerpen, Dienst Oftalmologie
Long-Term Non-Interventional Latanoprost Study
Leuven : Universitair Ziekenhuis Leuven - Campus Sint-Raphaël
Long-Term Non-Interventional Latanoprost Study
Oogheelkunde :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Brazil
São Paulo : Updated
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Bulgaria
Sofia : University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna - ISUL"
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Sofia : Specialized Hospital for Active Treatment for Eye Diseases "Zrenie"
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Canada
Vancouver :
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
Vaughan :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
China
Beijing :
A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension
Colombia
Bogotá : Updated
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Czech Republic
Brno : Fakultni nemocnice Brno
Long-Term Non-Interventional Latanoprost Study
Praha 5 : Fakultni nemocnice v Motole
Long-Term Non-Interventional Latanoprost Study
Denmark
Glostrup : Glostrup Hospital, Oegenafdelingen
Long-Term Non-Interventional Latanoprost Study
Estonia
Tallin : Eye Clinic Dr. Krista Turman
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Tallin : East Tallin Central Hospital
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Finland
Tampere : FinnMedi Oy, Clinical Trial Center
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
France
Lille Cedex : Hopital Claude Huriez
Long-Term Non-Interventional Latanoprost Study
Lyon :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Germany
Dresden :
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Freiburg : Universitaetsklinikum Freiburg
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Giessen : Universitaetsklinikum Giessen
Long-Term Non-Interventional Latanoprost Study
Hamburg : Universitaetsklinikum Hamburg-Eppendorf
Long-Term Non-Interventional Latanoprost Study
Karlsruhe :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
View More »
Köln : Uniklinik Köln
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Mainz : Universitaetsklinikum Mainz
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Mainz : Universitaetsklinikum Mainz
Long-Term Non-Interventional Latanoprost Study
Mainz :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Wiesloch :
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
Greece
Israel
Haifa : Bnei Zion Medical Center
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Petach Tikva :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Tel Aviv :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Italy
Catania : Azienda Ospedaliero Univ.
Long-Term Non-Interventional Latanoprost Study
Fiumicino (Roma) : Ospedale Pediatrico Bambino Gesu
Long-Term Non-Interventional Latanoprost Study
Milano : Unita' Operativa di Oculistica Pediatrica, Azienda Ospedaliera Ospedale Niguarda Ca'Grande
Long-Term Non-Interventional Latanoprost Study
Milano :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Mexico
Mexico City : Updated
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Netherlands
Amsterdam :
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Poland
Gdańsk :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Portugal
Slovakia
Spain
Barcelona : Institut Català de Retina
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Esplugues de Llobregat : Hospital Sant Joan de Deu
Long-Term Non-Interventional Latanoprost Study
Madrid : Hospital Universitario Ramón y Cajal
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Madrid : Hospital Universitario 12 de Octubre
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Madrid : Hospital Universitario Clínico San Carlos
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
View More »
Madrid : Hospital Clinico San Carlos
Long-Term Non-Interventional Latanoprost Study
Pamplona : Clinica Universidad Navarra
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Sevilla : Hospital Virgen Del Rocio
Long-Term Non-Interventional Latanoprost Study
Torrevieja :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Valencia :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Valladolid : Instituto de Oftalmobiología Aplicada
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Zaragoza : Hospital Universitario Miguel Servet
Long-Term Non-Interventional Latanoprost Study
Sweden
Uppsala : Akademiska Sjukhuset
Long-Term Non-Interventional Latanoprost Study
Vasteras : Ogonkliniken, Centrallasarett
Long-Term Non-Interventional Latanoprost Study
Turkey
Istanbul :
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
United Kingdom
